Advertisement
Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team
reuters.com
1 of 0
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) ExtendedRelease Tablets for the Treatment of ADHD in Children and Adolescents Aged 6to 17INTUNIV, the first nonscheduled alpha-2A
« Back to the FDA Approves Nonstimulant Shire Drug for ADHD WisdomCard
Advertisement
This site complies with the HONcode standard for trustworthy health information: verify here.
© 2012 OrganizedWisdom.com, Inc. All rights reserved.
OrganizedWisdom does not provide medical advice, diagnosis or treatment. If you think you
may have a medical emergency, call your doctor or 911 immediately.
As Seen In
